New York State Common Retirement Fund Verastem, Inc. Transaction History

New York State Common Retirement Fund

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$0.92 - $11.16 $1,104 - $13,403	-1,201 Reduced 1.78%	66,171 $56,000
Q2 2022 Aug 04, 2022	SELL	$1.02 - $1.83 $31,676 - $56,830	-31,055 Reduced 31.55%	67,372 $78,000
Q1 2022 May 05, 2022	BUY	$1.06 - $2.1 $301 - $596	284 Added 0.29%	98,427 $139,000
Q4 2021 Feb 02, 2022	BUY	$2.05 - $3.2 $15,983 - $24,950	7,797 Added 8.63%	98,143 $201,000
Q3 2021 Nov 02, 2021	SELL	$2.54 - $4.07 $97,454 - $156,157	-38,368 Reduced 29.81%	90,346 $278,000
Q2 2021 Aug 02, 2021	SELL	$2.57 - $4.85 $54,705 - $103,237	-21,286 Reduced 14.19%	128,714 $524,000
Q2 2020 Aug 07, 2020	BUY	$1.69 - $4.2 $253,500 - $630,000	150,000 New	150,000 $258,000
Q2 2019 Aug 09, 2019	SELL	$1.25 - $3.14 $75,750 - $190,284	-60,600 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$3.23 - $7.01 $5,168 - $11,216	1,600 Added 2.71%	60,600 $204,000
Q3 2018 Nov 07, 2018	BUY	$6.86 - $9.97 $93,982 - $136,589	13,700 Added 30.24%	59,000 $428,000
Q2 2018 Aug 10, 2018	BUY	$2.88 - $8.67 $130,464 - $392,751	45,300 New	45,300 $312,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.